NIH-funded research NIH-funded research

Immune clues to prevent cancer in Lynch Syndrome

Official title: Immune determinants modulating cancer development in Lynch Syndrome

Funded at Icahn School of Medicine at Mount Sinai · NIH-11457459 · Data updated 2026-11-12

A study exploring how immune signals and shared neoantigens in Lynch Syndrome could help prevent cancer by training the immune system to recognize and fight premalignant lesions.

More Lynch Syndrome research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJune 15, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$912,989
NIH project number4UH3CA290517-03
Project IDNIH-11457459 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with Lynch Syndrome or at high risk due to germline MMR deficiencies.

Less likely to help

People without Lynch Syndrome or with cancers not related to MMR defects may not benefit.

What this research studies

This project investigates how the body's immune system detects and responds to cancer-related changes in Lynch Syndrome, focusing on neoantigens created by mismatch repair defects. Researchers will look at how frameshift mutations generate shared targets across tumors and how T cells in blood reflect what happens inside tumors. The study also considers vaccination strategies and how early immune activation might stop premalignant polyps from turning into cancer. By combining immune profiling, biomarkers, and potential preventive approaches, the work aims to map paths to prevention in high-risk individuals.

Why it matters

Potential benefit: If successful, the work could lead to new prevention strategies and vaccines for people with Lynch Syndrome.

How similar studies have gone: Prior work has shown that neoantigen targets and T cell responses can be informative for CPI responses; this study builds on that by focusing on prevention in Lynch Syndrome.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Bhardwaj, Nina — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Bhardwaj, Nina

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.